Hodgson Ian Insider Trades

Insider Trading History

Track insider trading activity for Hodgson Ian. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Corbus Pharmaceuticals Holdings
Corbus Pharmaceuticals Holdings CRBP
Chief Operating Officer
Holding Value $409k 51,080 shares
Last Trade
Feb 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.25k 847 shares
$7.38
$8.01
Corbus Pharmaceuticals Holdings
Corbus Pharmaceuticals Holdings 0SZI.L
Chief Operating Officer
Holding Value $405k 51,080 shares
Last Trade
Feb 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.25k 847 shares
$7.38
$7.94
Corbus Pharmaceuticals Holdings
Corbus Pharmaceuticals Holdings CRBP
Chief Operating Officer
Holding Value $416k 51,927 shares
Last Trade
Feb 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$19.5k 2,415 shares
$8.09
$8.01
Corbus Pharmaceuticals Holdings
Corbus Pharmaceuticals Holdings 0SZI.L
Chief Operating Officer
Holding Value $412k 51,927 shares
Last Trade
Feb 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$19.5k 2,415 shares
$8.09
$7.94
Corbus Pharmaceuticals Holdings
Corbus Pharmaceuticals Holdings CRBP
Chief Operating Officer
Holding Value $682k 85,095 shares
Last Trade
Jan 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$937k 113,460 shares
$8.26
$8.01
Corbus Pharmaceuticals Holdings
Corbus Pharmaceuticals Holdings 0SZI.L
Chief Operating Officer
Holding Value $675k 85,095 shares
Last Trade
Jan 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$929k 113,460 shares
$8.19
$7.94

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up